Pitolisant Shows Promise for Prader-Willi Syndrome Symptoms
Harmony announced new data from its phase 2 study evaluating pitolisant for excessive daytime sleepiness in Prader-Willi syndrome.
Kumar Budur Foundation For Prader Willi Research Symposium Harmony Biosciences Holdings Inc Prader Willi Research Symposium Aberrant Behavioral Harmony Biosciences
Source: sleepreviewmag.com